Notebook

Molecular biologist John Fagan made nationwide headlines the week before Thanksgiving when he said thanks--but no thanks--to the National Institutes of Health, returning a grant of nearly $614,000. Fagan, a professor of molecular biology at Maharishi International University (MIU) in Fairfield, Iowa, returned the grant--for research on two genes that are blueprints for cytochromes P450, involved in carcinogen and toxin metabolism-

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Molecular biologist John Fagan made nationwide headlines the week before Thanksgiving when he said thanks--but no thanks--to the National Institutes of Health, returning a grant of nearly $614,000. Fagan, a professor of molecular biology at Maharishi International University (MIU) in Fairfield, Iowa, returned the grant--for research on two genes that are blueprints for cytochromes P450, involved in carcinogen and toxin metabolism--to protest genetic engineering, a field he believes is progressing too rapidly and without consideration of its harmful implications. Fagan, who got his Ph.D. from Cornell University in 1977 and was a research fellow at NIH before he joined MIU in 1991, brought a measure of respect to the institution, the site of 1994 Ig Nobel Prize-winning research concluding that meditators caused a decrease in violent crime in Washington, D.C. Losing the funding is "a big hit" for the school, acknowledges Fagan, who is redirecting his work toward cancer prevention ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies